• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Germany Extends Test Phase for ePrescriptions

Share:

January 18, 2022

The German Federal Ministry of Health (BMG) informed gematik, Germany’s national agency for digital medicine, on 20 December, that the nationwide implementation of digital prescriptions cannot be implemented as initially scheduled.

The launch of the mandatory ePrescription, scheduled for 1 January 2022, has been postponed while the national testing period started at the beginning of December, will continue during the early part of the year.

WHAT’S THE IMPACT

According to the Ministry, the necessary technical systems are “not yet available across the board” meaning that GP offices, pharmacies, hospitals, and insurers only need to comply with the mandate for digital prescriptions as of this year, if they already have the necessary technical infrastructure in place.

Paper-based prescriptions may therefore continue to be in circulation for the time being, according to the new decision at the BMG.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The main reason for extending the national trial phase is that there is too little experience in the digital prescription process overall. In the previous piloting period in Berlin and Brandenburg from mid-2021 until December, only 50 prescriptions were issued and billed instead of 1,000 as originally planned.

Austria, on the contrary, has issued 33,000 digital prescriptions within four months after piloting its ePrescription in 2021.

THE LARGER TREND

The electronic prescription process is intended to save healthcare providers and patients time, effort, and travel in the German health care system in the future. It is also intended to increase the safety of drug therapy for patients.

Once the rollout process has been completed nationwide, the obligation to prescribe digitally will then also apply to all healthcare providers across Germany: patients will then receive a prescription code together with intake and dosage instructions displayed in the gematik app after their medical consultation or video consultation.

They can choose to show and redeem the prescription code at a pharmacy of their choice or redeem it at an online pharmacy for delivery.

ON THE RECORD

Hannes Neumann, product manager at gematik GmbH, commented on the technical hurdles during the testing period: “The market share of the practice management systems certified by Kassenärztliche Bundesvereinigung (KBV) is now more than 90 percent. Certification is a prerequisite for the nationwide launch of the e-prescription.”

He added: “However, not all manufacturers have achieved certification in time to start testing in October and November. Other manufacturers do not have medical facilities with their installations in Berlin/Brandenburg and asked for an extension to other regions. The participation of hospitals also requires the installation of the corresponding updates by their system manufacturers. Some hospitals are currently on their way.”

Neumann sees great potential in the digital prescription process: “The e-prescription saves patients unnecessary trips, e.g. if the practice transmits follow-up prescriptions directly digitally to the app or prescribes it in a remote treatment. Insured persons can also pre-order medicines from home at the pharmacy of their choice and then pick them up or simply have them delivered.”

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • 10 Best Life Sciences Stocks For This Year – Top Stocks – TheStreet Ratings10 Best Life Sciences Stocks For This Year – Top Stocks – TheStreet Ratings
  • Bruker Announces Acquisition of Scientific Software Provider ArxspanBruker Announces Acquisition of Scientific Software Provider Arxspan
  • RapidAI Receives FDA 510(K) for Another Pulmonary Embolism ToolRapidAI Receives FDA 510(K) for Another Pulmonary Embolism Tool
  • Allina Health Partners with Epic-Based KeyCare PlatformAllina Health Partners with Epic-Based KeyCare Platform
  • Pulmodyne Acquiring Innovative ProductsPulmodyne Acquiring Innovative Products
  • Bigfoot Biomedical Caps off its Series C Funding at $55M, Including a New $10M AdditionBigfoot Biomedical Caps off its Series C Funding at $55M, Including a New $10M Addition
  • Ontrak Deepens Its Behavioral Health Platform with LifeDojo AcquisitionOntrak Deepens Its Behavioral Health Platform with LifeDojo Acquisition
  • Amgen Successfully Completes Acquisition of Teneobio, Inc.Amgen Successfully Completes Acquisition of Teneobio, Inc.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications